France AI in Precision Medicine Market Insight
Published: 29 May 2026 | Report Format: Electronic (PDF)
The France AI in Precision Medicine market size is growing at a 27.1% CAGR, driven by the rising genomic medicine adoption, increasing AI integration in healthcare, and stronger demand for personalized treatment solutions.
France AI in Precision Medicine Market Insights Forecasts to 2035
- The France AI in Precision Medicine Market Size Was Estimated at USD 440.09 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 27.1% from 2025 to 2035
- The France AI in Precision Medicine Market Size is Expected to Reach USD 4841.8 Million by 2035
Notable Insights for France AI in Precision Medicine Market
- The AI-powered genomic analytics segment leads the France AI in precision medicine market because it achieved about USD 150 million in sales during the year 2025. The segment stands as the market leader because precision medicine systems base their operations on genomic sequencing together with biomarker-based diagnostic approaches.
- The AI-driven drug discovery and predictive healthcare analytics segment will experience fast market expansion during the forecast period because it will achieve an estimated CAGR of 29%. The market experiences growth because healthcare providers now create personalized treatments while they use clinical data and increase their investment in artificial intelligence systems for medical care.
- France holds about 10% of the Europe AI in precision medicine market because it maintains strong biotechnology research programs and operates with advanced healthcare facilities.
- The France AI in precision medicine market generates about 34% of its revenue from genomic analytics because precision healthcare systems depend on personalized diagnostics and biomarker analysis for their core operations.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France AI in Precision Medicine market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France AI in Precision Medicine Market
- IBM Watson Health
- Tempus AI
- Illumina Inc.
- Roche Diagnostics
- Siemens Healthineers
- NVIDIA Corporation
- Google DeepMind Health
- Microsoft Corporation
- Sophia Genetics
- BioMérieux
- PathAI
- Owkin
- Others
Recent Developments:
- In March 2025, healthcare AI companies in France accelerated deployment of AI-powered genomic analytics platforms designed to improve precision oncology diagnostics and personalized treatment planning.
- In February 2025, biotechnology and pharmaceutical organizations expanded investment in AI-assisted biomarker discovery systems integrated with genomic sequencing technologies.
Market Segmentation:
France AI in Precision Medicine Market, By Component
- AI Software Platforms
- AI Services
- AI Infrastructure Solutions
- Data Analytics Platforms
- Others
France AI in Precision Medicine Market, By Technology
- Machine Learning
- Deep Learning
- Natural Language Processing (NLP)
- Computer Vision
- Predictive Analytics
- Generative AI
- Others
France AI in Precision Medicine Market, By Application
- Precision Oncology
- Genomic Data Analysis
- Biomarker Discovery
- Drug Discovery and Development
- Clinical Decision Support
- Rare Disease Diagnostics
- Predictive Healthcare Analytics
- Others
Expert Views:
The France AI in precision medicine market is expected to grow rapidly, driven by genomic sequencing expansion, AI-assisted diagnostics, precision oncology adoption, and predictive healthcare analytics. Companies emphasizing healthcare intelligence, genomic analytics, clinical accuracy, AI scalability, and regulatory compliance will strengthen long-term competitive market positioning.
Author: Govind and Krishna By Spherical Insights and Consulting